SRFMX
Price
$15.18
Change
+$0.07 (+0.46%)
Updated
Nov 19 closing price
Net Assets
88.49M
VFIAX
Price
$613.90
Change
+$2.31 (+0.38%)
Updated
Nov 19 closing price
Net Assets
1.46T
Interact to see
Advertisement

SRFMX vs VFIAX

Header iconSRFMX vs VFIAX Comparison
Open Charts SRFMX vs VFIAXBanner chart's image
Sarofim Equity
Price$15.18
Change+$0.07 (+0.46%)
VolumeN/A
Net Assets88.49M
Vanguard 500 Index Admiral
Price$613.90
Change+$2.31 (+0.38%)
VolumeN/A
Net Assets1.46T
SRFMX vs VFIAX Comparison Chart in %
View a ticker or compare two or three
VS
SRFMX vs. VFIAX commentary
Nov 20, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is SRFMX is a Hold and VFIAX is a Hold.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
VFIAX has more cash in the bank: 1.46T vs. SRFMX (88.5M). VFIAX pays higher dividends than SRFMX: VFIAX (1.11) vs SRFMX (0.38). SRFMX was incepted earlier than VFIAX: SRFMX (12 years) vs VFIAX (25 years). SRFMX (0.78) is less costly to investors than VFIAX (0.04). SRFMX is a more actively managed with annual turnover of: 13.00 vs. VFIAX (2.00). SRFMX has a lower initial minimum investment than VFIAX: SRFMX (2500) vs VFIAX (3000). VFIAX annual gain was more profitable for investors over the last year : 11.89 vs. SRFMX (-9.89). VFIAX return over 5 years is better than : 86.13 vs. SRFMX (0.36).
SRFMXVFIAXSRFMX / VFIAX
Total Expense Ratio0.700.041,750%
Annual Report Gross Expense Ratio0.780.041,950%
Fund Existence12 years25 years-
Gain YTD7.56112.72259%
Front LoadN/AN/A-
Min. Initial Investment2500300083%
Min. Initial Investment IRAN/AN/A-
Net Assets88.5M1.46T0%
Annual Yield % from dividends0.381.1135%
Returns for 1 year-9.8911.89-83%
Returns for 3 years4.5066.987%
Returns for 5 years0.3686.130%
Returns for 10 years62.26216.7829%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
RRACF11.51N/A
N/A
Rigel Resource Acquisition Corp.
CMOPF81.79N/A
N/A
Cosmo Pharmaceuticals NV
CNSWF2281.61-37.62
-1.62%
Constellation Software, Inc.
SPXSF90.10-6.60
-6.83%
SPIRAX GROUP PLC
PHRRF0.10-0.01
-7.42%
PharmaTher Holdings Ltd.